参考文献/References:
[1]Gurunathan A,Ricci K,Iacobas I,et al. Impact of vascular anomalies on the PTEN phenotype in children and young adults[J]. Pediatr Blood Cancer,2020,67(6):e28258.
[2]Niethamer TK,Bush JO. Getting direction(s):the Eph/ephrin signaling system in cell positioning[J]. Dev Biol,2019,447(1):42-57.
[3]Su SA,Xie Y,Zhang Y,et al. Essential roles of EphrinB2 in mammalian heart:from development to diseases[J]. Cell Commun Signal,2019,17(1):29.
[4]Yang D,Jin C,Ma H,et al. EphrinB2/EphB4 pathway in postnatal angiogenesis:a potential therapeutic target for ischemic cardiovascular disease[J].Angiogenesis, 2016,19(3):297-309.
[5]Tsakiroglou P,VandenAkker NE,Del Bo’C,et al. Role of berry anthocyanins and phenolic acids on cell migration and angiogenesis:an updated overview[J]. Nutrients,2019,11(5):1075.
[6]Luxán G,Stewen J,Díaz N,et al. Endothelial EphB4 maintains vascular integrity and transport function in adult heart[J]. Elife,2019,8:e45863.
[7]Chen K,Bai H,Liu Y,et al. EphB4 forward-signaling regulates cardiac progenitor development in mouse ES cells[J]. J Cell Biochem,2015,116(3):467-475.
[8]Park I,Lee HS. EphB/ephrinB signaling in cell adhesion and migration[J]. Mol Cells,2015,38(1):14-19.
[9]Gucciardo E,Sugiyama N,Lehti K. Eph- and ephrin -dependent mechanisms in tumor and stem cell dynamics[J]. Cell Mol Life Sci,2014,71(19):3685-3710.
[10]Pitulescu ME,Schmidt I,Giaimo BD,et al. Dll4 and Notch signalling couples sprouting angiogenesis and artery formation[J]. Nat Cell Biol,2017,19(8):915-927.
[11]Yuan C,Wang P,Zhu S,et al. Overexpression of ephrinB2 in stem cells from apical papilla accelerates angiogenesis[J]. Oral Dis,2019,25(3):848-859.
[12]Cao C,Huang Y,Tang Q,et al. Bidirectional juxtacrine ephrinB2/Ephs signaling promotes angiogenesis of ECs and maintains self-renewal of MSCs[J]. Biomaterials, 2018,172:1-13.
[13]Ho VC,Fong GH. Vasculogenesis and angiogenesis in VEGF receptor-1 deficient mice[J]. Methods Mol Biol,2015,1332:161-176.
[14]Groppa E,Brkic S,Uccelli A,et al. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF[J]. EMBO Rep,2018,19(5):e45054.
[15]Gong T,Xu J,Heng B,et al. EphrinB2/EphB4 signaling regulates DPSCs to induce sprouting angiogenesis of endothelial cells[J]. J Dent Res,2019,98(7):803-812.
[16]Chen D,Teng JM,North PE,et al. RASA1-dependent cellular export of collagen Ⅳ controls blood and lymphatic vascular development[J]. J Clin Invest, 2019,129(9):3545-3561.
[17]Xiao H,Huang Q,Wang JQ,et al. Effect of ephrin-B2 on the expressions of angiopoietin-1 and -2 after focal cerebral ischemia/reperfusion[J]. Neural Regen Res,2016,11(11):1784-1789.
[18]Buckens OJ,El Hassouni B,Giovannetti E,et al. The role of Eph receptors in cancer and how to target them:novel approaches in cancer treatment[J]. Expert Opin Investig Drugs,2020,29(6):567-582.
[19]Cheng N,Brantley DM,Liu H,et al. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis[J]. Mol Cancer Res,2002,1(1):2-11.
[20]Torres MJ,McLaughlin KL,Renegar RH,et al. Intracardiac administration of ephrinA1-Fc preserves mitochondrial bioenergetics during acute ischemia/reperfusion injury[J]. Life Sci,2019,239:117053.
[21]Le MNT,Hasegawa K. Expansion culture of human pluripotent stem cells and production of cardiomyocytes[J]. Bioengineering (Basel),2019,6(2):48.
[22]Kemmerling N,Wunderlich P,Theil S,et al. Intramembranous processing by γ-secretase regulates reverse signaling of ephrin-B2 in migration of microglia[J]. Glia,2017,65(7):1103-1118.
[23]Barquilla A,Pasquale EB. Eph receptors and ephrins:therapeutic opportunities[J]. Annu Rev Pharmacol Toxicol,2015,55:465-487.
[24]Protack CD,Foster TR,Hashimoto T,et al. Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency[J]. Sci Rep,2017,7(1):15386.
[25]Zheng LC,Wang XQ,Lu K,et al. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells[J]. Oncotarget, 2017,8(25):41348-41363.
相似文献/References:
[1]宋林声,综述,陆地,等.低剂量多巴酚丁胺负荷磁共振成像在缺血性心脏病中的应用研究[J].心血管病学进展,2016,(3):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
SONG Linsheng,LU Di,ZHAO Xinxiang.Low-dose Dobutamine Stress MRI Myocardial Perfusion and
Assessment of Myocardial Viability[J].Advances in Cardiovascular Diseases,2016,(2):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
[2]翟恒博,综述,刘俊,等.缺血性心脏病再认识[J].心血管病学进展,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
ZHAI Hengbo,LIU Jun.Rethinking of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(2):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
[3]肖轶 余国龙.不同干细胞来源的外泌体在缺血性心脏病中的促血管新生作用[J].心血管病学进展,2022,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
XIAO Yi,YU Guolong?/html>.Application of Exosomes Derived from Various Stem Cells?n Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(2):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
[4]琚敏 汪蕾 宋雷 方纬.心脏交感神经显像的临床应用和研究进展[J].心血管病学进展,2023,(1):16.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.005]
JU Min,WANG Lei,SONG Lei,et al.Clinical Application and Research Progress of Cardiac Sympathetic Imaging[J].Advances in Cardiovascular Diseases,2023,(2):16.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.005]
[5]庞自豪 贾青青 韩博文 张莉.药物调控哺乳动物雷帕霉素靶蛋白相关信号通路在缺血性心脏病中的研究进展[J].心血管病学进展,2024,(4):326.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.009]
PANG Zihao,JIA Qingqing,HAN Bowen,et al.Research Progress In Drug Regulated mTOR Related Signaling Pathway?span>In Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2024,(2):326.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.009]
[6]闻雪松 刘焕.β受体阻滞剂在心血管疾病中的研究及应用进展[J].心血管病学进展,2024,(7):632.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.013]
WEN Xuesong,LIU Huan.Role of -Blockers in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(2):632.[doi:10.16806/j.cnki.issn.1004-3934.2024.07.013]